DR antigens influence graft outcome and HCV recurrence after liver transplantation

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 1099-1100

  Kimball, P ^a   Stravitz, T ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR5 ANTIGEN;

COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; GRAFT SURVIVAL; HEPATITIS C; HEREDITY; HUMAN; INCIDENCE; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 17844410674     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.12.169     Document Type: Conference Paper

References (5)

1. L. Forman, J. Lewis, J. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889
2. H. Tillman, D. Chen, C. Trautwein Low frequency of HLA DRB1*11 in hepatitis C virus induced end stage liver disease Gut 48 2001 714
3. M. Asti, M. Martinetti, C. Zavaglia Human leukocyte antigen class II and III alleles and severity of hepatitis C virus related chronic liver disease Hepatology 29 1999 1272
4. L. Fanning, J. Levis, E. Kenny-Walsh Viral clearance in HCV infection: relationship with human leukocyte antigen class II in a homogeneous population Hepatology 31 2000 1334
5. L. Belli, C. Zavaglia, A. Alberti Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation Hepatology 31 2000 1345